Figure 4
Clinical Global Impression of Improvement (CGI-I) response rate (%) at prespecified time points during the 3-week treatment and 5-week follow-up period in lanicemine 100 mg, lanicemine 150 mg and placebo groups. Response is defined as CGI-I score⩽2 (much or very much improved) (phase IIB study, study 9).
